Unraveling the Potential of Hypericin: A Novel Approach to Targeting PCSK9 Mutations in Cholesterol Management
This study evaluates the binding of natural compounds to PCSK9 mutants using molecular docking and in silico analysis, identifying Hypericin as a promising candidate for cholesterol management.